Hyo-Jung Cho

27PUBLICATIONS
105CO-AUTHORS
Metabolic medicinePredictive and prognostic markersHaematological tumoursHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 31, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease and Vascular Complications: Associations with Serum Testosterone Levels in a Korean Multicenter Male Cohort.

|May 11, 2026
Plasma interleukin-8 as a predictive biomarker for tyrosine kinase inhibitor response in advanced hepatocellular carcinoma.

|Feb 04, 2026
Targeting Tumor-Associated Macrophages and Cancer-Associated Fibroblasts to Overcome Therapeutic Resistance in Hepatocellular Carcinoma.

Hyo Jung Cho, Minsu Kwon, Judith A Varner

|Aug 29, 2024
Effect of Sortilin1 on promoting angiogenesis and systemic metastasis in hepatocellular carcinoma via the Notch signaling pathway and CD133.

Hye Ri Ahn, Sujin Kim, Geum Ok Baek

|Jan 23, 2024
The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib.

Ji Eun Han, Jisu Kim, Jae Youn Cheong

|Aug 26, 2023
Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma.

Hyung Seok Kim, Jung Hwan Yoon, Geum Ok Baek

Pageof 5

Frequent Collaborators

17 joint publications

Soon Sun Kim

16 joint publications

Jae-Youn Cheong

11 joint publications

Jung Woo Eun

7 joint publications

Geum Ok Baek